A Phase 2/3, Randomized, Double-Masked, Sham-Controlled

Project: Research project

Project Details

Description

A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trail of QPI-1007 Delivered by Single or Multi- Dose Intravitreal Injection(s)to Subjects with Acute Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
StatusActive
Effective start/end date10/1/1512/31/21

Funding

  • Quark Pharmaceuticals, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.